Skip to main content

Table 1 Summary of analysed EBF3 and TBC1D16 CpG sites

From: Characterisation of DNA methylation changes in EBF3 and TBC1D16 associated with tumour progression and metastasis in multiple cancer types

Chromosome

GRCh37 loci

450k CpG site

RRBS coverage

Gene feature

Publication

chr10

131636623

cg07890827

NA

EBF3, gene body

[10]

131640007

cg09371530

131640304

cg16803064

131641337

cg09649486

131641581

cg25866634

131647544

cg03774288

131671490

cg09121772

131763135

cg02700606

EBF3, promoter

[9]

131763531

NA

58 bp fragment

131763539

131763541

131763543

131763546

131763548

131763550

131763558

131763577

131763589

chr17

77924372

cg18749563

NA

TBC1D16, gene body

[10, 13]

77924583

cg07618085

[13]

77924598

NA

87 bp fragment

NA

77924611

77924614

77924640

77924648

77924662

TBC1D16-45/47KD, cryptic promoter

77924666

cg17295878

[10, 13]

77924685

NA

NA

77924734

cg23651872

NA

[10]

77925137

cg19004465

[13]